Rare diseases
Investigational molecules
Locations
Emmy Noetherweg 2, 2333 BK Leiden, The Netherlands
VarmX B.V. focuses on clinical research in restoring coagulation for patients receiving factor Xa inhibitors or direct oral anticoagulants who need urgent surgery or invasive procedures with a high risk of bleeding.
The research activity is centered on clinical situations where rapid restoration of clotting function is needed to support procedural safety.
VarmX B.V. runs clinical trials in conditions such as Coagulation factor X level, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
